TrialPloS one2017

Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.

Christian Prebensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.